Skip to main content

Status of OCT angiography for diabetic retinopathy

Free for a limited time Diabetic Retinopathy Review

The applications of OCTA in diabetic retinopathy continue to grow. In particular, ultrawide field OCTA and AI based on OCTA images are making advances in terms of diagnostic accuracy.

Denosumab associated with lower risk for incident diabetes

28-02-2024 Type 2 Diabetes News

People with osteoporosis who continue with denosumab after their first dose are less likely to develop diabetes than those who discontinue therapy.

Update on menopausal HRT and type 2 diabetes

Open Access Type 2 Diabetes Review

Menopausal HRT may reduce the risk of type 2 diabetes developing and improve glycemic control. Individual risk factors must be considered when deciding a treatment plan.

How do metabolic diseases affect migraine?

Open Access Migraine Review

Migraine is associated with highly prevalent metabolic diseases, such as obesity, diabetes, and hypothyroidism. Understanding this relationship, and how metabolic diseases impact the efficacy of antimigraine drugs, is essential for optimal migraine treatment.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Bruns–Garland syndrome as the initial manifestation of type 2 diabetes

Open Access Type 2 Diabetes Case Study

Diabetic radiculoplexus neuropathy, or Bruns–Garland syndrome, is a rare form of microvascular complication that more commonly affects the lumbosacral plexus and, very rarely, the cervical plexus.

HNF1A gene mutations and primary ovarian failure

Open Access Primary Ovarian Insufficiency Case Study

HNF1A mutations are responsible for maturity-onset diabetes of the young (MODY). Coexistence of POF and MODY 3 in an adolescent girl raised the idea that these mutations might also have a role in POF.

Late onset of immune checkpoint inhibitor-induced type 1 diabetes

Open Access Type 1 Diabetes Case Study

A patient with small-cell lung cancer developed type 1 diabetes many weeks after receiving serplulimab, highlighting the need for continued monitoring of blood glucose levels and early signs and symptoms of diabetes.

Current Reviews

Advances in basic research on glucagon and alpha cells

The regulation of plasma amino acid levels by glucagon in humans first attracted the attention of researchers in the 1980s. Recent basic research using animal models of glucagon deficiency suggested that a major physiological role of glucagon is …

Experiences and Outcomes of Indigenous Patients Undergoing Bariatric Surgery: a Mixed-Method Scoping Review

Obesity and type 2 diabetes (T2D) are growing global health concerns. Evidence suggests that Indigenous peoples are at higher lifetime risk of obesity and its associated conditions. Obesity increases the risk of T2D, cardiovascular disease, and …

Cost-Effectiveness of Routine Monitoring of Long-Term Conditions in Primary Care: Informing Decision Modelling with a Systematic Review in Hypertension, Type 2 Diabetes and Chronic Kidney Disease

Open Access Chronic Kidney Disease Systematic Review

Long-term conditions (LTCs) such as high blood pressure (hypertension), type-2 diabetes mellitus and chronic kidney disease (CKD) are major public health problems. About 26 million people in England suffer from at least one LTC [ 1 ]; about 8.3 …

Tirzepatide: A Review in Type 2 Diabetes

Tirzepatide Adis Drug Evaluation

Tirzepatide (Mounjaro®), a first-in-class dual incretin agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, is approved for use as an adjunct to diet and exercise to improve glycaemic …

eLearning | Infographic (Link opens in a new window)

An independent educational program featuring simulated patient consultations. Make knowledge-based decisions on diagnosis and management of CKD with and without co-morbidities, and learn from experts Kevin Fernando and David Wheeler.

Supported by:
  • AstraZeneca
Developed by: Springer Healthcare IME

Digital Treatment Map (Link opens in a new window)

Practical, expert-led digital map designed to guide treatment of type 2 diabetes with GLP‑1RAs.

This program is not available to users in the UK and US.

Supported by:
  • Novo Nordisk A/S
Developed by: Springer Healthcare IME

Webcast | Videos (Link opens in a new window)

1.0 AMA PRA Category 1 Credit(s)

Discussion-based webcast addressing the causes of clinical inertia in type 2 diabetes.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME

Further Reading

Automatic Detection of 30 Fundus Diseases Using Ultra-Widefield Fluorescein Angiography with Deep Experts Aggregation

Open Access Angiography ORIGINAL RESEARCH

Millions of people in the world suffer from ocular fundus diseases such as diabetic retinopathy (DR) [ 1 ], retinal vein occlusion (RVO) [ 2 ], age-related macular degeneration (AMD) [ 3 ], retinal detachment (RD) [ 4 ], optic neuropathy, and …

Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank

Open Access Albuminuria Original Research

Chronic kidney disease (CKD) develops in approximately 40% of people with type 2 diabetes [ 1 ] and is associated with increased risk of CVD and mortality [ 2 ]. Diabetes is associated with two- to fourfold increased risk of CVD [ 3 ], whereas …

Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment

Open Access Type 2 Diabetes Original Research

Heart failure is a chronic and complex disease that poses a significant public health concern. Heart failure with preserved ejection fraction (HFpEF) constitutes approximately 50–55% of heart failure and its prevalence is increasing at a rate of …

Intake of B vitamins and the risk of developing islet autoimmunity and type 1 diabetes in the TEDDY study

Open Access Type 1 Diabetes Original Contribution

Type 1 diabetes (T1D) is characterized by the appearance of circulating islet autoantibodies indicating islet autoimmunity (IA) before clinical diagnosis [ 1 ]. Both genetic and environmental factors contribute to the development of IA and T1D. It …

Related topics

Open Access Type 2 Diabetes Case Study

Bruns–Garland syndrome as the initial manifestation of type 2 diabetes

Diabetic radiculoplexus neuropathy, or Bruns–Garland syndrome, is a rare form of microvascular complication that more commonly affects the lumbosacral plexus and, very rarely, the cervical plexus.

Read more
Open Access Type 2 Diabetes Review

Update on menopausal HRT and type 2 diabetes

Menopausal HRT may reduce the risk of type 2 diabetes developing and improve glycemic control. Individual risk factors must be considered when deciding a treatment plan.

Read more
Open Access Type 2 Diabetes Case Study

Bruns–Garland syndrome as the initial manifestation of type 2 diabetes

Diabetic radiculoplexus neuropathy, or Bruns–Garland syndrome, is a rare form of microvascular complication that more commonly affects the lumbosacral plexus and, very rarely, the cervical plexus.

Read more